Empliciti
elotuzumab
Multiple Myeloma
Date of authorisation:
Revision: 12
Last updated:
MedicineHumanAuthorised
EMEA-002377-PIP01-18 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Oncology
PIP number: P/0267/2018
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for concentrate for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Kynamro
mipomersen sodium
Hypercholesterolemia
Date of refusal:
Last updated:
MedicineHumanRefused
EMEA-000928-PIP01-10-M01 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism
PIP number: P/139/2011
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman